Unexplained weight loss (UWL) is a clinical conundrum often encountered in practice. This phenomenon, defined as a loss of more than 5% of body weight over a period of 6-12 months without a known cause, can be indicative of underlying serious illnesses. A systematic and comprehensive approach to its evaluation is crucial to ensure timely diagnosis and intervention.
The first step is a thorough history and physical examination. Key aspects to investigate include dietary habits, medication use, psychosocial factors, and symptoms suggestive of systemic diseases. A comprehensive review of systems can help identify potential causes such as malignancy, endocrine disorders, gastrointestinal diseases, and psychiatric illnesses.
Following the initial evaluation, laboratory investigations should be tailored based on the findings. Basic tests include complete blood count, metabolic panel, thyroid function tests, and inflammatory markers. Imaging studies and endoscopies may be warranted in some cases. If these investigations fail to reveal a cause, a more extensive workup, including tests for rare diseases, may be considered.
Management of UWL hinges on treating the underlying cause. In cases where no cause is identified, a watchful waiting approach may be adopted, with periodic reassessments. Nutritional support should be provided to all patients, and those with significant weight loss may require referral to a dietitian.
Evaluating unexplained weight loss requires a systematic and comprehensive approach. While it can be challenging, understanding the potential underlying causes and maintaining a high index of suspicion for serious illnesses is essential. A meticulous history, physical examination, and judicious use of investigations can facilitate diagnosis and timely intervention, ultimately improving patient outcomes.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation